格隆汇1月19日丨宏柏新材(605366.SH)在投资者互动平台表示，公司产品有出口至欧盟成员国家，相关 业务收入占有一定比例。公司对欧盟市场的销售方式有直接销售，也有通过贸易商和代理商进行销售。 ...

证券代码：605366 证券简称：宏柏新材 公告编号：2026-003 债券代码：111019 债券简称：宏柏转债 江西宏柏新材料股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1.业绩预告的具体适用情形：净利润为负值。 2.经财务部门初步测算，江西宏柏新材料股份有限公司（以下简称"公司"） 预计 2025 年年度实现归属于母公司所有者的净利润为-15,000.00 万元到 -11,000.00 万元。 2.公司预计 2025 年年度实现归属于母公司所有者的扣除非经常性损益的净 利润为-16,500.00 万元到-12,000.00 万元。 （三）本期业绩预告未经注册会计师审计。 二、上年同期经营业绩和财务状况 （一）利润总额：-4,188.85 万元。归属于母公司所有者的净利润：-3,086.71 万元。归属于母公司所有者的扣除非经常性损益的净利润：-3,817.26 万元。 （二）每股收益：-0.05 元。 3.公司预计 2025 年年度实现归属于母公司所有者的扣除非 ...

Core Viewpoint - Hongbo New Materials announced an expected net profit attributable to the parent company for the year 2025 to be between -150 million yuan and -110 million yuan, indicating a significant loss forecast for the upcoming year [2] Financial Performance - The company anticipates a net profit attributable to the parent company, excluding non-recurring gains and losses, to be between -165 million yuan and -120 million yuan for the year 2025 [2]

Core Viewpoint - The company expects a significant net loss for the fiscal year 2025, with projections indicating a net profit attributable to shareholders ranging from -150 million to -110 million yuan, and a net profit excluding non-recurring losses between -165 million and -120 million yuan [1] Group 1: Financial Performance - The anticipated net profit for 2025 is projected to be between -150 million and -110 million yuan [1] - The expected net profit excluding non-recurring losses is forecasted to be between -165 million and -120 million yuan [1] Group 2: Reasons for Performance - The company cites an imbalance in supply and demand within the industry, leading to intense competition, despite a steady year-on-year increase in product sales volume [1] - The company has incurred increased depreciation and operational costs due to the conversion of construction projects into fixed assets [1] - There has been a rise in related expenses, including costs associated with the implementation of an equity incentive plan and increased interest expenses on convertible bonds compared to the previous year [1]

Core Viewpoint - The company expects a net loss of 150 million to 110 million yuan for the year 2025 due to various operational challenges and increased costs [1] Group 1: Economic Environment - The macroeconomic environment has weakened, leading to an imbalance in supply and demand across the industry, with intense competition persisting [1] - Despite a steady year-on-year increase in sales volume of the company's main products, the selling prices remain at historically low levels [1] Group 2: Operational Costs - The company has ongoing construction projects that have transitioned to fixed assets, resulting in increased depreciation and operational costs [1] - There has been an increase in related expenses, including costs associated with the implementation of an equity incentive plan and higher interest expenses on convertible bonds compared to the previous year [1]

Core Viewpoint - Hongbo New Materials (605366.SH) is expected to report a net profit attributable to shareholders of the parent company ranging from -150 million to -110 million yuan for the fiscal year 2025 [1] Financial Performance - The company anticipates a net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, to be between -165 million and -120 million yuan for the fiscal year 2025 [1]

Core Viewpoint - Hongbo New Materials (605366.SH) has issued a preliminary announcement indicating an expected net loss for the fiscal year 2025, with the net profit attributable to shareholders projected to be negative [1] Financial Performance - In 2024, Hongbo New Materials achieved an operating revenue of 1.477 billion yuan, representing a year-on-year increase of 6.68% [1] - The net profit attributable to shareholders for 2024 was -30.87 million yuan, compared to a profit of 64.97 million yuan in the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -38.17 million yuan, down from 41.74 million yuan year-on-year [1] - The net cash flow from operating activities was 277 million yuan, showing a year-on-year growth of 41.97% [1] Fundraising Activities - Hongbo New Materials was listed on the Shanghai Stock Exchange on August 12, 2020, issuing 83 million shares at a price of 9.98 yuan per share, raising a total of 828.34 million yuan [2] - The company issued convertible bonds totaling 960 million yuan in May 2024, with 67.17% of the bonds allocated to existing shareholders [2] - The total amount raised from the two fundraising activities is 1.788 billion yuan [3] Dividend Distribution - In 2022, the company distributed a cash dividend of 0.16 yuan per share and increased its capital stock by 0.3 shares per share, resulting in a total cash dividend distribution of 53.71 million yuan [3] - In 2023, the company distributed a cash dividend of 0.25 yuan per share and increased its capital stock by 0.4 shares per share, with a total cash dividend distribution of 109.35 million yuan [3]

Group 1 - Shoukai Co. achieved a signed area of 125.72 million square meters and a signed amount of 17.845 billion yuan in 2025 [1] - Tongda Hai expects a net loss for the year 2025 [2] - Jiuri New Materials' subsidiary has entered the trial production phase for a project with an annual capacity of 350 tons of hydroxy ketone [3] Group 2 - Jixin Technology's shareholder plans to reduce their stake by up to 1% [4] - Fulai New Materials received approval from the CSRC for a stock issuance [5] - Yaqi International plans to sign a strategic cooperation framework agreement with Zhongnong Holdings [6] Group 3 - Sanwei Co.'s controlling shareholder plans to transfer up to 5.10% of shares [7] - Lekai Film's subsidiary plans to invest 97.6675 million yuan in a TAC functional film production line [8] - China Power Construction's subsidiary signed two major contracts totaling approximately 15.589 billion yuan [9] Group 4 - Shunhao Co. plans to increase its investment in a subsidiary by 74.98 million yuan [10] - Jieneng Wind Power reported a cumulative power generation of 12.417 billion kWh in 2025, a year-on-year increase of 1.43% [11] - Zhongjian Technology's H-share issuance application has been accepted by the CSRC [12] Group 5 - Hendi Pharmaceutical expects a net profit decrease of 57.4% to 66.14% in 2025 [13] - Haopeng Technology anticipates a net profit increase of 113.69% to 141.09% in 2025 [14] - Lingang Co. expects a net loss of 1.45 billion to 1.67 billion yuan in 2025 [15] Group 6 - Chuan Investment Energy reported a cumulative power generation of 6.627 billion kWh in 2025, a year-on-year increase of 13.85% [16] - Tengyuan Cobalt expects a net profit increase of 50.02% to 69.87% in 2025 [17] - Huazhi Jie plans to repurchase shares worth 30 million to 50 million yuan [18] Group 7 - Opto has won a bid for a 120 million yuan project from GoerTek [19] - Shanghai Construction reported a new contract amount of 252.942 billion yuan in 2025, a year-on-year decrease of 34.98% [20] - Hangfa Control expects a net profit decrease of 52.02% to 58.02% in 2025 [22] Group 8 - Shimao Energy is planning a change in control and will continue to suspend trading [23] - Shenwan Hongyuan Securities received approval for a bond issuance of up to 60 billion yuan [24] - Jingjiawei signed a strategic cooperation letter of intent with Jing'an Technology [25] Group 9 - Pianzaihuang completed the first subject enrollment for a clinical trial of a new drug [26] - Placo's subsidiary received a new veterinary drug registration certificate [27] - Zhongli Co. plans to reduce its stake by up to 0.75% [28] Group 10 - Solar Energy received renewable energy subsidies of 3.318 billion yuan in 2025, a year-on-year increase of 142.9% [29] - Palm Co. has filed a lawsuit to recover 144 million yuan in project payments [30][31] - Yongjin Co. plans to invest 2.658 billion yuan in a new stainless steel project [32] Group 11 - BAIC Blue Valley plans to increase its stake by 14.5 million to 16.4 million yuan [33] - Lingyun Light's stock issuance application has been approved by the CSRC [34] - Hongbo New Materials expects a net loss in 2025 [35] Group 12 - Shanghai Pharmaceuticals received approval for the listing of a new antifungal drug [36] - Changjiang Electric reported a net profit of 34.167 billion yuan in 2025, a year-on-year increase of 5.14% [37] - Weilan Bio received a new veterinary drug registration certificate [38] Group 13 - Pingzhi Information's subsidiary is expected to win a procurement project worth approximately 37.5884 million yuan [39]

Financial Performance - The company expects a net profit attributable to shareholders to be negative for the fiscal year 2025, indicating an anticipated loss[2] Compliance and Reporting - The company is accelerating its financial accounting processes to comply with the Shanghai Stock Exchange listing rules[2] - The final financial data will be disclosed in the audited annual report for 2025, which will be released within the stipulated timeframe[2]

每经AI快讯，1月13日，宏柏新材（605366）(605366.SH)公告称，宏柏新材发布2025年度业绩预告，预 计归属于上市公司股东的净利润为负值。报告期内，公司经营业绩出现亏损。 ...